Análisis de la acción Baxter International Inc. (BAX)BAXBaxter International Inc.

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. Its products are used in hospitals, rehabilitation centers, ambulatory surgery centers, and others. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Baxter International Inc is currently priced at $26.13, which is near the average analyst price target of $28. The stock has a forward P/E ratio of 13.12, suggesting it may be fairly valued based on future earnings. However, the RSI is at 43.88, indicating that the stock is nearing oversold territory, which could present a buying opportunity. The main risk is the recent negative net income trend, with a significant loss of $1.12 billion reported in Q4 2025, which raises concerns about profitability moving forward.